Beneficial effects of FeTSPP, a peroxynitrite decomposition catalyst, in a mouse model of spinal cord injury

Free Radical Biology and Medicine

Volumn 43, Issue 5, 2007, Pages 763-780

  Genovese, Tiziana ^a,b   Mazzon, Emanuela ^a,b   Esposito, Emanuela ^b,c   Muià, Carmelo ^a   Di Paola, Rosanna ^a,b   Bramanti, Placido ^b   Cuzzocrea, Salvatore ^a,b  

^a UNIVERSITY OF MESSINA   (Italy)

^b IRCCS CENTRO NEUROLESI BONINO PULEJO   (Italy)

^c UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

FeTSPP; Peroxynitrite; Spinal cord injury

Indexed keywords

3 NITROTYROSINE; 5 10 15 20 TETRAKIS(4 SULFONATOPHENYL)PORPHYRINATO IRON III CHLORIDE; CYTOKINE; DEXAMETHASONE; DNA DIRECTED DNA POLYMERASE ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NITRITE; PROTEIN BAX; PROTEIN BCL 2; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CATALYST; CELL DEATH; CELL INFILTRATION; CONTROLLED STUDY; DECOMPOSITION; DISEASE SEVERITY; DRUG DOSE REDUCTION; DRUG EFFECT; ENZYME ACTIVATION; MALE; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPINAL CORD INJURY; TISSUE INJURY; WESTERN BLOTTING;

ANIMALS; CATALYSIS; DISEASE MODELS, ANIMAL; DNA; I-KAPPA B PROTEINS; INTERLEUKIN-1BETA; INTERLEUKIN-2; LIPID PEROXIDATION; MALE; METALLOPORPHYRINS; MICE; MITOCHONDRIA; NEUTROPHIL INFILTRATION; NF-KAPPA B; PEROXIDASE; PEROXYNITROUS ACID; PHOSPHORYLATION; POLY(ADP-RIBOSE) POLYMERASES; PROTEIN TRANSPORT; PROTO-ONCOGENE PROTEINS C-BCL-2; RNA; SPINAL CORD INJURIES; T-LYMPHOCYTES; TUMOR NECROSIS FACTOR-ALPHA; TYROSINE;

MUS;

EID: 34547098160     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2007.05.012     Document Type: Article

References (60)

1. Pineau I., and Lacroix S. Proinflammatory cytokine synthesis in the injured mouse spinal cord: multiphasic expression pattern and identification of the cell types involved. J. Comp. Neurol. 500 (2007) 267-285
2. Amar A.P., and Levy M.L. Pathogenesis and pharmacological strategies for mitigating secondary damage in acute spinal cord injury. Neurosurgery 44 (1999) 1027-1039 (discussion 1039-1040)
3. Bao F., DeWitt D.S., Prough D.S., and Liu D. Peroxynitrite generated in the rat spinal cord induces oxidation and nitration of proteins: reduction by Mn (III) tetrakis (4-benzoic acid) porphyrin. J. Neurosci. Res. 71 (2003) 220-227
4. Bao F., and Liu D. Peroxynitrite generated in the rat spinal cord induces neuron death and neurological deficits. Neuroscience 115 (2002) 839-849
5. Bao F., and Liu D. Peroxynitrite generated in the rat spinal cord induces apoptotic cell death and activates caspase-3. Neuroscience 116 (2003) 59-70
6. Liu D., Bao F., Prough D.S., and Dewitt D.S. Peroxynitrite generated at the level produced by spinal cord injury induces peroxidation of membrane phospholipids in normal rat cord: reduction by a metalloporphyrin. J. Neurotrauma 22 (2005) 1123-1133
7. Liu D., Ling X., Wen J., and Liu J. The role of reactive nitrogen species in secondary spinal cord injury: formation of nitric oxide, peroxynitrite, and nitrated protein. J. Neurochem. 75 (2000) 2144-2154
8. Scott G.S., Jakeman L.B., Stokes B.T., and Szabo C. Peroxynitrite production and activation of poly (adenosine diphosphate-ribose) synthetase in spinal cord injury. Ann. Neurol. 45 (1999) 120-124
9. Scott G.S., Szabo C., and Hooper D.C. Poly(ADP-ribose) polymerase activity contributes to peroxynitrite-induced spinal cord neuronal cell death in vitro. J. Neurotrauma 21 (2004) 1255-1263
10. Xiong Y., Rabchevsky A.G., and Hall E.D. Role of peroxynitrite in secondary oxidative damage after spinal cord injury. J. Neurochem. 100 (2007) 639-649
11. Xu J., Kim G.M., Chen S., Yan P., Ahmed S.H., Ku G., Beckman J.S., Xu X.M., and Hsu C.Y. iNOS and nitrotyrosine expression after spinal cord injury. J. Neurotrauma 18 (2001) 523-532
12. Bolanos J.P., Heales S.J., Land J., and Clark J.B. Effect of peroxynitrite on the mitochondrial respiratory chain: differential susceptibility of neurones and astrocytes in primary culture. J. Neurochem. 64 (1995) 1965-1972
13. Blanchard-Fillion B., Souza J.M., Friel T., Jiang G.C., Vrana K., Sharov V., Barron L., Schoneich C., Quijano C., Alvarez B., Radi R., Przedborski S., Fernando G.S., Horwitz J., and Ischiropoulos H. Nitration and inactivation of tyrosine hydroxylase by peroxynitrite. Biol. Chem. 276 (2001) 46017-46023
14. Alvarez B., and Radi R. Peroxynitrite reactivity with amino acids and proteins. Amino Acids 25 (2003) 295-311
15. Genovese T., Mazzon E., Muia C., Bramanti P., De Sarro A., and Cuzzocrea S. Attenuation in the evolution of experimental spinal cord trauma by treatment with melatonin. J. Pineal. Res. 38 (2005) 198-208
16. Salvemini D., Wang Z.Q., Stern M.K., Currie M.G., and Misko T.P. Peroxynitrite decomposition catalysts: therapeutics for peroxynitrite-mediated pathology. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 2659-2663
17. Groves J.T. Peroxynitrite: reactive, invasive and enigmatic. Curr. Opin. Chem. Biol. 3 (1999) 226-235
18. Misko T.P., Highkin M.K., Veenhuizen A.W., Manning P.T., Stern M.K., Currie M.G., and Salvemini D. Characterization of the cytoprotective action of peroxynitrite decomposition catalysts. J. Biol. Chem. 273 (1998) 15646-15653
19. Salvemini D., Jensen M.P., Riley D.P., and Misko T.P. Therapeutic manipulations of peroxynitrite. Drug News Perspect. 11 (1998) 204-214
20. Jensen M.P., and Riley D.P. Peroxynitrite decomposition activity of iron porphyrin complexes. Inor. Chem. 41 (2002) 4788-4797
21. Cuzzocrea S., Misko T.P., Costantino G., Mazzon E., Micali A., Caputi A.P., Macarthur H., and Salvemini D. Beneficial effects of peroxynitrite decomposition catalyst in a rat model of splanchnic artery occlusion and reperfusion. FASEB J. 14 (2000) 1061-1072
22. Cuzzocrea S., Mazzon E., Di Paola R., Esposito E., Macarthur H., Matuschak G.M., and Salvemini D. A role for nitric oxide-mediated peroxynitrite formation in a model of endotoxin-induced shock. J. Pharmacol. Exp. Ther. 319 (2006) 73-81
23. Mullane K. Neutrophil-platelet interactions and post-ischemic myocardial injury. Prog. Clin. Biol. Res. 301 (1989) 39-51
24. Ohkawa H., Ohishi N., and Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal. Biochem. 95 (1979) 351-358
25. Sirin B.H., Ortac R., Cerrahoglu M., Saribulbul O., Baltalarli A., Celebisoy N., Iskesen I., and Rendeci O. Ischaemic preconditioning reduces spinal cord injury in transient ischaemia. Acta Cardiol. 57 (2002) 279-285
26. Bethea J.R., Castro M., Keane R.W., Lee T.T., Dietrich W.D., and Yezierski R.P. Traumatic spinal cord injury induces nuclear factor-kappaB activation. J. Neurosci. 18 (1998) 3251-3260
27. Basso D.M., Beattie M.S., and Bresnahan J.C. A sensitive and reliable locomotor rating scale for open field testing in rats. J. Neurotrauma 12 (1995) 1-21
28. Joshi M., and Fehlings M.G. Development and characterization of a novel, graded model of clip compressive spinal cord injury in the mouse: Part 2. Quantitative neuroanatomical assessment and analysis of the relationships between axonal tracts, residual tissue, and locomotor recovery. J. Neurotrauma 19 (2002) 191-203
29. Joshi M., and Fehlings M.G. Development and characterization of a novel, graded model of clip compressive spinal cord injury in the mouse: Part 1. Clip design, behavioral outcomes, and histopathology. J. Neurotrauma 19 (2002) 175-190
30. Cuzzocrea S., Genovese T., Mazzon E., Crisafulli C., Min W., Di Paola R., Muia C., Li J.H., Esposito E., Bramanti P., Xu W., Massuda E., Zhang J., and Wang Z.Q. Poly(ADP-ribose) glycohydrolase activity mediates post-traumatic inflammatory reaction after experimental spinal cord trauma. J. Pharmacol. Exp. Ther. 319 (2006) 127-138
31. Genovese T., Mazzon E., Mariotto S., Menegazzi M., Cardali S., Conti A., Suzuki H., Bramanti P., and Cuzzocrea S. Modulation of nitric oxide homeostasis in a mouse model of spinal cord injury. J. Neurosurg. Spine 4 (2006) 145-153
32. Glaser J., Gonzalez R., Sadr E., and Keirstead H.S. Neutralization of the chemokine CXCL10 reduces apoptosis and increases axon sprouting after spinal cord injury. Neurosci. Res. 84 (2006) 724-734
33. Tator C.H. Review of experimental spinal cord injury with emphasis on the local and systemic circulatory effects. Neurochirurgie 37 (1991) 291-302
34. Anderson D.K., and Hall E.D. Pathophysiology of spinal cord trauma. Ann. Emerg. Med. 22 (1993) 987-992
35. Salvemini D., Doyle T.M., and Cuzzocrea S. Superoxide, peroxynitrite and oxidative/nitrative stress in inflammation. Biochem. Soc. Trans. 34 (2006) 965-970
36. Crow J.P., and Beckman J.S. The role of peroxynitrite in nitric oxide-mediated toxicity. Curr. Top. Microbiol. Immunol. 196 (1995) 57-73
37. Eiserich J.P., Hristova M., Cross C.E., Jones A.D., Freeman B.A., Halliwell B., and van der Vliet A. Formation of nitric oxide-derived inflammatory oxidants by myeloperoxidase in neutrophils. Nature 391 (1998) 393-397
38. Pacher P., Beckman J.S., and Liaudet L. Nitric oxide and peroxynitrite in health and disease. Physiol. Rev. 87 (2007) 315-424
39. Beckman J.S., Beckman T.W., Chen J., Marshall P.A., and Freeman B.A. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc. Natl. Acad. Sci. U. S. A. 87 (1990) 1620-1624
40. Bowie A., and O'Neill L.A. Oxidative stress and nuclear factor-kappaB activation: a reassessment of the evidence in the light of recent discoveries. Biochem. Pharmacol. 59 (2000) 13-23
41. Haddad J.J. Antioxidant and prooxidant mechanisms in the regulation of redox(y)-sensitive transcription factors. Cell Signal. 14 (2002) 879-897
42. Verma I.M. Nuclear factor (NF)-kappaB proteins: therapeutic targets. Ann. Rheum. Dis. 63 Suppl 2 (2004) ii57-ii61
43. Genovese T., Mazzon E., Crisafulli C., Di Paola R., Muia C., Bramanti P., and Cuzzocrea S. Immunomodulatory effects of etanercept in an experimental model of spinal cord injury. J. Pharmacol. Exp. Ther. 316 (2006) 1006-1016
44. Streit W.J., Semple-Rowland S.L., Hurley S.D., Miller R.C., Popovich P.G., and Stokes B.T. Cytokine mRNA profiles in contused spinal cord and axotomized facial nucleus suggest a beneficial role for inflammation and gliosis. Exp. Neurol. 152 (1998) 74-87
45. Liu J., Marino M.W., Wong G., Grail D., Dunn A., Bettadapura J., Slavin A.J., Old L., and Bernard C.C. TNF is a potent anti-inflammatory cytokine in autoimmune-mediated demyelination. Nat. Med. 4 (1998) 78-83
46. Ousman S.S., and David S. MIP-1alpha, MCP-1, GM-CSF, and TNF-alpha control the immune cell response that mediates rapid phagocytosis of myelin from the adult mouse spinal cord. J. Neurosci. 21 (2001) 4649-4656
47. Shafit-Zagardo B., Sharma N., Berman J.W., Bornstein M.B., and Brosnan C.F. CSF-1 expression is upregulated in astrocyte cultures by IL-1 and TNF and affects microglial proliferation and morphology in organotypic cultures. Int. J. Dev. Neurosci. 11 (1993) 189-198
48. Sharma H.S., Winkler T., Stalberg E., Gordh T., Alm P., and Westman J. Topical application of TNF-alpha antiserum attenuates spinal cord trauma induced edema formation, microvascular permeability disturbances and cell injury in the rat. Acta Neurochir., Suppl. 86 (2003) 407-413
49. Genovese T., Mazzon E., Rossi A., Di Paola R., Cannavo G., Muia C., Crisafulli C., Bramanti P., Sautebin L., and Cuzzocrea S. Involvement of 5-lipoxygenase in spinal cord injury. J. Neuroimmunol. 166 (2005) 55-64
50. Crocker S.J., Whitmire J.K., Frausto R.F., Chertboonmuang P., Soloway P.D., Whitton J.L., and Campbell I.L. Persistent macrophage/microglial activation and myelin disruption after experimental autoimmune encephalomyelitis in tissue inhibitor of metalloproteinase-1-deficient mice. Am. J. Pathol. 169 (2006) 2104-2116
51. Holtz A., Nystrom B., and Gerdin B. Spinal cord injury in rats: inability of nimodipine or anti-neutrophil serum to improve spinal cord blood flow or neurologic status. Acta Neurol. Scand. 79 (1989) 460-467
52. Fan L.H., Wang K.Z., Cheng B., Wang C.S., and Dang X.Q. Anti-apoptotic and neuroprotective effects of Tetramethylpyrazine following spinal cord ischemia in rabbits. BMC Neurosci. 7 (2006) 48
53. Scholz J., Broom D.C., Youn D.H., Mills C.D., Kohno T., Suter M.R., Moore K.A., Decosterd I., Coggeshall R.E., and Woolf C.J. Blocking caspase activity prevents transsynaptic neuronal apoptosis and the loss of inhibition in lamina II of the dorsal horn after peripheral nerve injury. J. Neurosci. 25 (2005) 7317-7323
54. Woodhouse A., Vincent A.J., Kozel M.A., Chung R.S., Waite P.M., Vickers J.C., West A.K., and Chuah M.I. Spinal cord tissue affects ensheathing cell proliferation and apoptosis. NeuroReport 16 (2005) 737-740
55. Merrill J.E., Ignarro L.J., Sherman M.P., Melinek J., and Lane T.E. Microglial cell cytotoxicity of oligodendrocytes is mediated through nitric oxide. J. Immunol. 151 (1993) 2132-2141
56. Wang J.Y., Shum A.Y., Ho Y.J., and Wang J.Y. Oxidative neurotoxicity in rat cerebral cortex neurons: synergistic effects of H2O2 and NO on apoptosis involving activation of p38 mitogen-activated protein kinase and caspase-3. J. Neurosci. Res. 72 (2003) 508-519
57. Chittenden T., Harrington E.A., O'Connor R., Flemington C., Lutz R.J., Evan G.I., and Guild B.C. Induction of apoptosis by the Bcl-2 homologue Bak. Nature 374 (1995) 733-736
58. Bar-Peled O., Knudson M., Korsmeyer S.J., and Rothstein J.D. Motor neuron degeneration is attenuated in bax-deficient neurons in vitro. J. Neurosci. Res. 55 (1999) 542-556
59. Pieper A.A., Verma A., Zhang J., and Snyder S.H. Poly (ADP-ribose) polymerase, nitric oxide and cell death. Trends Pharmacol. Sci. 20 (1999) 171-181
60. LaPlaca M.C., Raghupathi R., Verma A., Pieper A.A., Saatman K.E., Snyder S.H., and McIntosh T.K. Temporal patterns of poly(ADP-ribose) polymerase activation in the cortex following experimental brain injury in the rat. J. Neurochem. 73 (1999) 205-213